| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
CSIRO Division of Molecular Biology, P. O. Box 184, North Ryde, New South Wales, 2113, [T. E. A., N. A. A., G. W. G.]; CSIRO Division of Mathematics and Statistics, P. O. Box 218, New South Wales, Lindfield, 2070 [R. J. C.]; CSIRO Division of Applied Organic Chemistry, Box 4331, G. P. O., Melbourne, Victoria 3001 [N. K. H., J. A. L.]; and CSIRO Division of Food Research, P. O. Box 52, North Ryde, New South Wales, 2113 [A. L.], Australia
While having no antitumor effect per se, caffeine substantially enhanced the antitumor effects of the phleomycins PLM-CHP and PLM-PEP, and the bleomycins BLM-CHP and Blenoxane in rats carrying Walker 256 carcinosarcoma and/or mice carrying Ehrlich ascites tumor, even at doses of phleomycin and bleomycin below the minimum effective level. Positive but less conclusive results were also obtained with PLM-A4A4G and PLM-G.
1 To whom requests for reprints should be addressed.
Received 3/26/84. Revised 12/26/84. Accepted 2/ 1/85.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |